-
Johnson & Johnson Shares Strong Since Actelion Acquisition, But Potential For Upside Remains
Thursday, July 20, 2017 - 11:40am | 404Read More...Johnson & Johnson (NYSE: JNJ) shares are up about 20 percent since the company acquired Actelion back in January. However, despite the strong performance, Credit Suisse analyst Vamil Divan sees more upside ahead for the pharma giant. On Thursday, Credit Suisse reinstated coverage of Johnson...
-
Exondys Sales, Takeover Speculation Fuel Sarepta Therapeutics
Friday, April 28, 2017 - 11:31am | 380Read More...Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are up more than 6.5 percent Friday after the company reported first-quarter net revenue from EXONDYS 51 of $16.3 million and guided for $95 million in revenue for the full year, up from previous guidance of $80 million. In addition to the revenue beat...
-
Dow Earnings: High Hopes For Chevron, Johnson & Johnson
Monday, January 23, 2017 - 9:31am | 617Read More...More than a third of the Dow components are expected to report earnings this week. Only a health care giant and an oil supermajor are expected to show solid growth on both the top and bottom lines. Both have beat earnings expectations in recent quarters. We are in the heart of the fourth-quarter...
-
Stifel Downgrades InterMune; Roche Offer 'Appropriate Ending'
Monday, August 25, 2014 - 11:34am | 329Read More...Shares of InterMune (NASDAQ: ITMN) were downgraded to Hold from Buy by Stifel following Roche's proposed $8.3 billion acquisition over the weekend. InterMune has been the subject of various takeover rumors. On August 13, Bloomberg reported that Roche, along with other European drug markers...
-
Jefferies & Company Maintains Actelion Buy Rating
Tuesday, November 9, 2010 - 9:14am | 115Read More...In a report released this morning, Jefferies & Company said that it believes Actelion (ATLN.VX) marketed products and cash largely underpin the current share price, with potential 2011E positive pipeline news driving upside. “Underappreciated pipeline programmes include selexipag, macitentan,...
